Liraglutide Treatment in Obese Infertile PCOS Women

This study tests whether liraglutide (a GLP-1 medication also used for weight loss and diabetes) can improve the chances of successful embryo implantation in obese women with polycystic ovary syndrome (PCOS) who are undergoing frozen embryo transfer as part of IVF. **You may be eligible if...** - You are a woman between 20 and 40 years old - You have been diagnosed with PCOS - Your BMI is between 25 and 35 kg/m² - You have at least one frozen embryo available for transfer at the research center - You have not used weight-loss medications (other than metformin) in the past 3 months **You may NOT be eligible if...** - Your blood sugar (HbA1c) is 9% or higher - You have uncontrolled thyroid disease, high blood pressure, or autoimmune conditions - You have serious heart, liver, or kidney disease - You have a history of 3 or more failed embryo implantations or 2 or more miscarriages - You have a personal or family history of medullary thyroid cancer - You are a current smoker, heavy drinker, or drug user - You have participated in another clinical trial in the past 3 months Talk to your doctor to see if this trial is right for you.